Polaryx Therapeutics PLYX
NASDAQ PLYX
$1.92 -0.02 (-1.04%)
As of: Oct 22, 2026 · 12:52 PM EDT

Polaryx Therapeutics (PLYX) Enterprise Value (2026)

Updated

Polaryx Therapeutics' Enterprise Value came in at $121.05 million for Q2 2026, down 65.9% from the prior quarter.

Analysis

Polaryx Therapeutics (PLYX) Enterprise Value (2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Polaryx Therapeutics reported Enterprise Value of $108.2 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,166.82 Bn 1,135.41 Bn 19.71 Bn
2 Johnson & Johnson 644.52 Bn 564.38 Bn 17.30 Bn
3 AbbVie 501.88 Bn 474.99 Bn 12.70 Bn
4 Merck 358.72 Bn 313.10 Bn 12.21 Bn
5 Novartis Ag 302.27 Bn 266.26 Bn 11.24 Bn
6 Astrazeneca 267.62 Bn 241.31 Bn 12.86 Bn
7 Amgen 241.67 Bn 197.07 Bn 7.24 Bn
8 Gilead Sciences 193.09 Bn 167.28 Bn 6.22 Bn
9 Pfizer 171.60 Bn 118.24 Bn 10.94 Bn
10 Polaryx Therapeutics 92.68 Mn 68.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 121.05 Mn
Mar 31, 2026 354.84 Mn
API Access

Polaryx Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=PLYX&period=max&api_key=YOUR_API_KEY